BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Innis BL, Scorza FB, Blum JS, Jain VK, Aguilar AO, Post DJ, Roberts PC, Wairagkar N, White J, Bresee J. Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations. Vaccine 2019;37:4830-4. [PMID: 31362820 DOI: 10.1016/j.vaccine.2019.06.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. The Lancet 2022;400:693-706. [DOI: 10.1016/s0140-6736(22)00982-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH, Gellin BG, Golding JP, Hart PJ, Moen A, Weller CL, Osterholm MT; Influenza Vaccines R&D Roadmap Taskforce. A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. Vaccine 2021;39:6573-84. [PMID: 34602302 DOI: 10.1016/j.vaccine.2021.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
3 Patel A, Walters JN, Reuschel EL, Schultheis K, Parzych E, Gary EN, Maricic I, Purwar M, Eblimit Z, Walker SN, Guimet D, Bhojnagarwala P, Adeniji OS, Doan A, Xu Z, Elwood D, Reeder SM, Pessaint L, Kim KY, Cook A, Chokkalingam N, Finneyfrock B, Tello-Ruiz E, Dodson A, Choi J, Generotti A, Harrison J, Tursi NJ, Andrade VM, Dia Y, Zaidi FI, Andersen H, Abdel-Mohsen M, Lewis MG, Muthumani K, Kim JJ, Kulp DW, Humeau LM, Ramos SJ, Smith TRF, Weiner DB, Broderick KE. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model. Cell Rep Med 2021;2:100420. [PMID: 34604818 DOI: 10.1016/j.xcrm.2021.100420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Nguyen LC, Bakerlee CW, McKelvey TG, Rose SM, Norman AJ, Joseph N, Manheim D, McLaren MR, Jiang S, Barnes CF, Kinniment M, Foster D, Darton TC, Morrison J. Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development. Clin Infect Dis 2021;72:710-5. [PMID: 32628748 DOI: 10.1093/cid/ciaa935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
5 Douglas AD, Hill AVS. Immunological considerations for SARS-CoV-2 human challenge studies. Nat Rev Immunol 2020;20:715-6. [PMID: 33087904 DOI: 10.1038/s41577-020-00472-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
6 Innis BL, Berlanda Scorza F, Blum JS, Jain VK, Older Aguilar A, Post DJ, Roberts PC, Wairagkar N, White J, Bresee J. Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity. Vaccine 2019;37:4823-9. [PMID: 31362819 DOI: 10.1016/j.vaccine.2019.06.080] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Krammer F, Weir JP, Engelhardt O, Katz JM, Cox RJ. Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines. Influenza Other Respir Viruses 2020;14:237-43. [PMID: 31837101 DOI: 10.1111/irv.12706] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
8 Metzger WG, Ehni HJ, Kremsner PG, Mordmüller BG. Experimental infections in humans-historical and ethical reflections. Trop Med Int Health 2019;24:1384-90. [PMID: 31654450 DOI: 10.1111/tmi.13320] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 [DOI: 10.1101/2020.07.28.225649] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Reference Citation Analysis]